5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effects of sunitinib versus interferon-alfa in health-related quality of life in patients with metastatic renal cell carcinoma (MRCC): Results from a randomized multinational phase III trial
    Meeting Abstract

    Cello, D.; Li, J.; Cappelleri, J. C.; Bushmakin, A.; Kim, S. T.; Chen, I.; Motzer, R. J.
    European Urology, Supplements (2007)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQOL) and kidney cancer-related symptoms in patients with metastatic renal cell carcinoma (MRCC) treated with sunitinib versus interferon (IFN)-alfa in a randomised, multinational phase III trial: Results for European and US subsample analyses
    Meeting Abstract

    Cella, D.; Li, J. Z.; Bushmakin, A. G.; Cappelleri, J. C.; Kim, S. T.; Chen, F.; Charbonneau, C.; Motzer, R. J.
    Value in Health (2007)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of AGS-PSCA, an anti-PSCA human antibody, in castration-resistant prostate cancer
    Meeting Abstract

    Carducci, M. A.; Morris, M. J.; Eisenberger, M. A.; Pili, R.; Denmeade, S. R.; Slovin, S. F.; Kelsen, M.; Jacobovits, A.; Vincent, M.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Regarding the focal treatment of prostate cancer: Inference of the Gleason grade from MR spectroscopic imaging
    Meeting Abstract

    Brame, R. S.; Zaider, M.; Zakian, K. L.; Koutcher, J. A.; Shukla-Dave, A.; Reuter, V. E.; Zelefsky, M. J.; Hricak, H.
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save
  • Structural model selection for 17-DMAG, a comparison of helrarchical bayesian approaches (PKBUGS) and frequentist adaptations of this approach in nonmem and PDX-MCPEM
    Meeting Abstract

    Bies, R. R.; Guzy, S.; Ramanathan, R. K.; Belani, C. P.; Solit, B.; Scher, H. I.; Holleran, J. L.; Ivy, P. S.; Egorin, M. J.
    Clinical Pharmacology & Therapeutics (2007)

    Fulltext@MSK | Save
  • Prostate specific membrane antigen (PSMA) expression in primary prostatic adenocarcinoma: Comparison of expression with gleason grade and hormonal therapy
    Meeting Abstract

    Al-Ahmadie, H. A.; Prakash, S.; Gopalan, A.; Olgac, S.; Tickoo, S. K.; Fine, S. W.; Scher, H. I.; Reuter, V. E.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • Prostate specific membrane antigen (PSMA) expression in primary prostatic adenocarcinoma: Comparison of expression with gleason grade and hormonal therapy
    Meeting Abstract

    Al-Ahmadie, H. A.; Prakash, S.; Gopalan, A.; Olgac, S.; Tickoo, S. K.; Fine, S. W.; Scher, H. I.; Reuter, V. E.
    Modern Pathology (2007)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors
    Journal Article

    Kondagunta, G. V.; Motzer, R. J.
    Urologic Clinics of North America (2007)

    Fulltext@MSK | Save
  • Innovations and challenges in prostate cancer: Summary statement for the 6th Cambridge conference
    Journal Article

    Kantoff, P. W.; Beer, T. M.; D'Amico, A. V.; DiPaola, R. S.; Eisenberger, M. A.; Hussain, M. H. A.; Kelly, W. K.; Mathew, P.; Morris, M. J.; Ryan, C. J.; more...
    Journal of Urology (2007)

    Fulltext@MSK | Save
  • Identification of novel androgen receptor target genes in prostate cancer
    Journal Article

    Jariwala, U.; Prescott, J.; Jia, L.; Barski, A.; Pregizer, S.; Cogan, J. P.; Arasheben, A.; Tilley, W. D.; Scher, H. I.; Gerald, W. L.; more...
    Molecular Cancer (2007)

    Fulltext@MSK | Save